The 13th European Conference on Clinical Neuroimaging (ECCN) will again bring together physicians and researchers from all brain imaging modalities (from PET to SPECT and MRI) and will also provide a window into other innovative biomarkers, new technologies and emerging areas of clinical neuroimaging. The conference will be held in Madrid, Spain from March 24th-26th, 2025.

On Tuesdy 25 March from 12:30-13:15, an AMYPAD satellite symposium sponsored by Life Molecular Imaging will be held:

Title: “What does AMYPAD study reveal about centiloid relevance for the future clinical setting?”

•  5’ Introduction – Dr. Andrew Stephens
• 15’ Clinical value of AMYPAD study – Prof. Pierre Payoux
• 15’ Centiloid recommendations for clinical context-of-use in challenging cases – Dr. Lyduine Collij
• 10’ Questions & discussion

We are looking forward to seeing you in Madrid!

You can find more information about the conference here: https://www.euroccn.com/